Exploring the "chemo"in chemoimmunotherapy for triple-negative breast cancer

被引：1

作者：

Liu, Ting ^{[1
,2
]}

Ellisen, Leif W. ^{[1
,2
,3
]}

机构：

[1] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA

[2] Harvard Med Sch, Boston, MA 02115 USA

[3] Ludwig Ctr Harvard, Boston, MA 02115 USA

来源：

CANCER CELL | 2025年 / 43卷 / 03期

关键词：

D O I：

10.1016/j.ccell.2025.02.016

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In this issue of Cancer Cell, Zhang et al. use single-cell RNA sequencing to compare immune cell dynamics in triple-negative breast cancers treated with the PD-L1 inhibitor atezolizumab plus paclitaxel or nab-paclitaxel. They identify distinct T cell activation patterns and highlight mast cells' role in immune activation exclusively in the nab-paclitaxel combination.

引用

页码：332 / 334

页数：3

共 9 条

[1] Human lung cancer harbors spatially organized stem-immunity hubs associated with response to immunotherapy [J].

Chen, Jonathan H. ;

Nieman, Linda T. ;

Spurrell, Maxwell ;

Jorgji, Vjola ;

Elmelech, Liad ;

Richieri, Peter ;

Xu, Katherine H. ;

Madhu, Roopa ;

Parikh, Milan ;

Zamora, Izabella ;

Mehta, Arnav ;

Nabel, Christopher S. ;

Freeman, Samuel S. ;

Pirl, Joshua D. ;

Lu, Chenyue ;

Meador, Catherine B. ;

Barth, Jaimie L. ;

Sakhi, Mustafa ;

Tang, Alexander L. ;

Sarkizova, Siranush ;

Price, Colles ;

Fernandez, Nicolas F. ;

Emanuel, George ;

He, Jiang ;

Van Raay, Katrina ;

Reeves, Jason W. ;

Yizhak, Keren ;

Hofree, Matan ;

Shih, Angela ;

Sade-Feldman, Moshe ;

Boland, Genevieve M. ;

Pelka, Karin ;

Aryee, Martin J. ;

Mino-Kenudson, Mari ;

Gainor, Justin F. ;

Korsunsky, Ilya ;

Hacohen, Nir .

NATURE IMMUNOLOGY, 2024, 25 (04) :644-658

[2] Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer [J].

Cortes, J. ;

Rugo, H. S. ;

Cescon, D. W. ;

Im, S-A ;

Yusof, M. M. ;

Gallardo, C. ;

Lipatov, O. ;

Barrios, C. H. ;

Perez-Garcia, J. ;

Iwata, H. ;

Masuda, N. ;

Otero, M. Torregroza ;

Gokmen, E. ;

Loi, S. ;

Guo, Z. ;

Zhou, X. ;

Karantza, V ;

Pan, W. ;

Schmid, P. .

NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (03) :217-226

[3] Interruption of the intratumor CD8+ T cell:Treg crosstalk improves the efficacy of PD-1 immunotherapy [J].

Geels, Shannon N. ;

Moshensky, Alexander ;

Sousa, Rachel S. ;

Murat, Claire ;

Bustos, Matias A. ;

Walker, Benjamin L. ;

Singh, Rima ;

Harbour, Stacey N. ;

Gutierrez, Giselle ;

Hwang, Michael ;

Mempel, Thorsten R. ;

Weaver, Casey T. ;

Nie, Qing ;

Hoon, Dave S. B. ;

Ganesan, Anand K. ;

Othy, Shivashankar ;

Marangoni, Francesco .

CANCER CELL, 2024, 42 (06) :1051-1066.e7

[4] Epigenetic signature of PD-1+TCF1+CD8 T cells that act as resource cells during chronic viral infection and respond to PD-1 blockade [J].

Jadhav, Rohit R. ;

Im, Se Jin ;

Hu, Bin ;

Hashimoto, Masao ;

Li, Peng ;

Lin, Jian-Xin ;

Leonard, Warren J. ;

Greenleaf, William J. ;

Ahmed, Rafi ;

Goronzy, Jorg J. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (28) :14113-14118

[5] Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte Function [J].

La Fleur, Linnea ;

Botling, Johan ;

He, Fei ;

Pelicano, Catarina ;

Zhou, Chikai ;

He, Chenfei ;

Palano, Giorgia ;

Mezheyeuski, Artur ;

Micke, Patrick ;

Ravetch, Jeffrey, V ;

Karlsson, Mikael C., I ;

Sarhan, Dhifaf .

CANCER RESEARCH, 2021, 81 (04) :956-967

[6] Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer [J].

Schmid, Peter ;

Cortes, Javier ;

Dent, Rebecca ;

McArthur, Heather ;

Pusztai, Lajos ;

Kuemmel, Sherko ;

Denkert, Carsten ;

Park, Yeon Hee ;

Hui, Rina ;

Harbeck, Nadia ;

Takahashi, Masato ;

Im, Seock-Ah ;

Untch, Michael ;

Fasching, Peter A. ;

Mouret-Reynier, Marie-Ange ;

Foukakis, Theodoros ;

Ferreira, Marta ;

Cardoso, Fatima ;

Zhou, Xuan ;

Karantza, Vassiliki ;

Tryfonidis, Konstantinos ;

Aktan, Gursel ;

O'Shaughnessy, Joyce .

NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (21) :1981-1991

[7] Focus on mast cells in the tumor microenvironment: Current knowledge and future directions [J].

Shi, Saimeng ;

Ye, Longyun ;

Yu, Xianjun ;

Jin, Kaizhou ;

Wu, Weiding .

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2023, 1878 (01)

[8] Distinct cellular mechanisms underlie chemotherapies and PD-L1 blockade combinations in triple-negative breast cancer [J].

Zhang, Yuanyuan ;

Chen, Hongyan ;

Mo, Hongnan ;

Zhao, Ning ;

Sun, Xiaoying ;

Liu, Baolin ;

Gao, Ranran ;

Xu, Binghe ;

Zhang, Zemin ;

Liu, Zhihua ;

Ma, Fei .

CANCER CELL, 2025, 43 (03) :446-463.e7

[9] Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer [J].

Zhang, Yuanyuan ;

Chen, Hongyan ;

Mo, Hongnan ;

Hu, Xueda ;

Gao, Ranran ;

Zhao, Yahui ;

Liu, Baolin ;

Niu, Lijuan ;

Sun, Xiaoying ;

Yu, Xiao ;

Wang, Yong ;

Chang, Qing ;

Gong, Tongyang ;

Guan, Xiuwen ;

Hu, Ting ;

Qian, Tianyi ;

Xu, Binghe ;

Ma, Fei ;

Zhang, Zemin ;

Liu, Zhihua .

CANCER CELL, 2021, 39 (12) :1578-+

← 1 →